UK funds biotech projects to accelerate species adaptation
Gene-edited butterflies and tree vaccines among 14 high-risk projects to combat climate threats.
1Radical biotech interventions
The UK's Advanced Research and Invention Agency (Aria) is funding 14 projects using CRISPR gene-editing and RNA interference to help species adapt to climate change. Projects include developing vaccines for ash trees against fungal diseases and modifying swallowtail butterflies' resistance to farm insecticides. This £54m program specifically targets species struggling with rapid environmental changes, focusing on precision biotech tools rather than traditional conservation methods.
2Controversial conservation approach
The initiative represents a significant shift in conservation strategy, moving from habitat protection to active genetic intervention. While 90 NGOs recently raised concerns about irreversible ecosystem impacts at the IUCN congress, Aria's ethical framework follows the IUCN's first global policy on synthetic biology. All research will be confined to secure labs until 2030, with no field releases during testing phases. The program chair emphasizes stringent ethical codes for these experimental solutions.
3Species-specific solutions
Each project addresses specific climate threats: Rothamsted Research aims to accelerate oak reproduction cycles from decades to months, while Imperial College collaborates on engineering protective skin bacteria for amphibians vulnerable to chytrid fungus. Cardiff University's ash tree 'vaccination' uses RNA molecules to block fungal infection pathways. These targeted approaches reflect growing recognition that some species can't evolve naturally fast enough to survive current environmental pressures.
4Scientific and political context
Aria was conceived by Dominic Cummings to fund high-risk, high-reward science that could restore UK research leadership. However, the agency faces scrutiny after its chair resigned over conflicts of interest with AI firm Anthropic. The £30m initial funding will be distributed among universities and research institutions, with an additional £24m available for successful projects after two years. Grantees must demonstrate lab effectiveness before seeking DEFRA approval for field applications.
5Technical implementation challenges
Researchers emphasize these are controlled experiments - no genetically modified organisms will be released during the program. The swallowtail butterfly project at Exeter University uses CRISPR-Cas9 to modify insecticide resistance genes, while the amphibian project engineers symbiotic bacteria rather than the animals themselves. This 'shield' approach aims to minimize ecological disruption while providing targeted protection against specific threats like skin-eating fungi.
6Scientific skepticism remains
Chris Thomas of York University cautions that impacts may be modest and difficult to measure, noting some amphibian species naturally develop resistance to chytrid fungus. He warns against overestimating biotechnology's role in biodiversity preservation, emphasizing that most solutions require extensive testing before field deployment. The program acknowledges these interventions won't replace addressing root causes of environmental change but could buy time for critically threatened species.
7Regulatory hurdles ahead
All projects must clear rigorous DEFRA assessments for genetically modified organism release, following the UK's historically strict GMO policies. The ash dieback vaccine faces particular scrutiny as it involves introducing foreign RNA into ecosystems. Aria's ethical committee chair notes the IUCN policy provides guidelines, but each application will require case-by-case evaluation. Success metrics will include both scientific efficacy and minimal ecosystem disruption.
8Future conservation paradigm
This program signals a potential turning point in conservation biology, where genetic tools complement traditional methods. While critics warn of unintended consequences, proponents argue such interventions may become necessary for species facing existential threats from rapid climate change. The projects' outcomes could establish precedents for how governments balance ecological preservation with advanced biotechnology, particularly for keystone species like pollinators and foundation trees.